by mozay | Jan 28, 2026 | Uncategorized
The Limits of Precision in Modern Clinical Trials Introduction: The Technology Paradox Clinical trials have never had access to more advanced technology, yet enrollment has rarely been more challenging. Across therapeutic areas, and particularly in retina, sponsors...
by mozay | Jan 28, 2026 | Uncategorized
Over 50%. That’s the current screen failure rate across more than 350 active clinical trials in the retina space. Half of all potential participants never move past the initial screening phase. This wasn’t always the case, but it has become the new reality and a stark...
